NR1I2 and colonic neoplasm: In the current study, our data reveal that PXR promotes viability and reduces DNA damage of liver and colon cancer cells after IR, providing a clue to overcoming radioresistance in liver and colon cancers where PXR is expressed by targeting PXR.